These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38127789)

  • 1. Predicting Surface pH in Unbuffered Conditions for Acids, Bases, and Their Salts - A Review of Modeling Approaches and Their Performance.
    Casalini T; Mann J; Pepin X
    Mol Pharm; 2024 Feb; 21(2):513-534. PubMed ID: 38127789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH.
    Li S; Wong S; Sethia S; Almoazen H; Joshi YM; Serajuddin AT
    Pharm Res; 2005 Apr; 22(4):628-35. PubMed ID: 15846471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts. II: Salicylic acid, theophylline, and benzoic acid.
    Serajuddin AT; Jarowski CI
    J Pharm Sci; 1985 Feb; 74(2):148-54. PubMed ID: 3989683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical Analysis of Drug Dissolution: I. Solubility and Intrinsic Dissolution Rate.
    Shekunov B; Montgomery ER
    J Pharm Sci; 2016 Sep; 105(9):2685-2697. PubMed ID: 26906172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution of ionizable drugs in buffered and unbuffered solutions.
    Ozturk SS; Palsson BO; Dressman JB
    Pharm Res; 1988 May; 5(5):272-82. PubMed ID: 3244637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical bases and their hydrochloride salts. I: Phenazopyridine.
    Serajuddin AT; Jarowski CI
    J Pharm Sci; 1985 Feb; 74(2):142-7. PubMed ID: 3989682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.
    Salehi N; Kuminek G; Al-Gousous J; Sperry DC; Greenwood DE; Waltz NM; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2021 Sep; 18(9):3326-3341. PubMed ID: 34428047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the maximal solubility advantage of drug salts.
    Skrdla PJ
    Int J Pharm; 2021 Feb; 595():120228. PubMed ID: 33484924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disproportionation of Pharmaceutical Salts: pH
    Avdeef A
    Mol Pharm; 2021 Jul; 18(7):2724-2743. PubMed ID: 34142831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-metric solubility. 3. Dissolution titration template method for solubility determination.
    Avdeef A; Berger CM
    Eur J Pharm Sci; 2001 Dec; 14(4):281-91. PubMed ID: 11684402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying the diffusion layer of soluble salts of poorly soluble basic drugs to improve dissolution performance.
    Hawley M; Morozowich W
    Mol Pharm; 2010 Oct; 7(5):1441-9. PubMed ID: 20731341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass Transport Analysis of Bicarbonate Buffer: Effect of the CO
    Al-Gousous J; Salehi N; Amidon GE; Ziff RM; Langguth P; Amidon GL
    Mol Pharm; 2019 Jun; 16(6):2626-2635. PubMed ID: 31013101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases.
    Krieg BJ; Taghavi SM; Amidon GL; Amidon GE
    J Pharm Sci; 2015 Sep; 104(9):2894-904. PubMed ID: 25980464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution kinetics of carboxylic acids I: effect of pH under unbuffered conditions.
    Mooney KG; Mintun MA; Himmelstein KJ; Stella VJ
    J Pharm Sci; 1981 Jan; 70(1):13-22. PubMed ID: 7229925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.
    Salehi N; Al-Gousous J; Mudie DM; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2020 Oct; 17(10):3870-3884. PubMed ID: 32886520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salt Solubility and Disproportionation - Uses and Limitations of Equations for pH
    Avdeef A; Sugano K
    J Pharm Sci; 2022 Jan; 111(1):225-246. PubMed ID: 34863819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biorelevant in vitro Tools and in silico Modeling to Assess pH-Dependent Drug-drug Interactions for Salts of Weak Acids: Case Example Potassium Raltegravir.
    Segregur D; Mann J; Moir A; Karlsson EM; Dressman J
    J Pharm Sci; 2022 Feb; 111(2):517-528. PubMed ID: 34597624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution of ionizable drugs into unbuffered solution: a comprehensive model for mass transport and reaction in the rotating disk geometry.
    Southard MZ; Green DW; Stella VJ; Himmelstein KJ
    Pharm Res; 1992 Jan; 9(1):58-69. PubMed ID: 1589411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution of acidic and basic compounds from the rotating disk: influence of convective diffusion and reaction.
    McNamara DP; Amidon GL
    J Pharm Sci; 1986 Sep; 75(9):858-68. PubMed ID: 3783452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.